Business Context and Reporting Period
This Form 8-K Current Report is filed by American Vanguard Corporation for the reporting period ending December 31, 2014. The filing primarily addresses the appointment of a new executive officer at AMVAC Chemical Corporation, the registrant's principal operating subsidiary.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on personnel changes and compensatory arrangements rather than financial performance data.
Material Changes
The material change reported is the appointment of Bob Trogele as Executive Vice President and Chief Operating Officer of AMVAC Chemical Corporation, effective December 31, 2014. Mr. Trogele was designated as an executive officer of the Corporation effective January 5, 2015.
Guidance, Outlook, and Management Commentary
- Compensatory Arrangements: Mr. Trogele entered into a three-year employment agreement with the following terms:
- Annual base salary: $360,000.
- Initial bonus: $150,000 (payable 30 days after commencement).
- Restricted Stock: 30,000 shares vesting in four equal tranches (7,500 shares) on the 90th day and the first, second, and third anniversaries of commencement.
- Performance Shares: 7,500 shares tied to the Corporation's financial performance for the three-year period commencing January 1, 2015.
- Severance: In the event of termination without cause, the greater of (x) annual base wage and health insurance for the remainder of the term, or (y) one year's base wage and health insurance.
- Background: Mr. Trogele, age 57, brings experience from FMC Corporation, where he served as President – Asia Pacific and North American Director of the agchem business group.
- Risks and Contingencies: The filing notes that the information is furnished under Items 5.02, 8.01, and 9.01 and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, limiting liability for the statements contained herein.
Investor Verification Checklist
- Verify the vesting schedule and performance metrics for the 7,500 performance shares awarded to Mr. Trogele.
- Confirm the total potential severance payout under the "termination without cause" clause relative to the remaining contract term.
- Review the attached press release (Exhibit 99.1) for additional strategic context regarding the appointment.
- Check subsequent filings for any changes to the executive compensation structure or performance targets.